Correlation Between Bank Central and Reneo Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Bank Central and Reneo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank Central and Reneo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bank Central Asia and Reneo Pharmaceuticals, you can compare the effects of market volatilities on Bank Central and Reneo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank Central with a short position of Reneo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank Central and Reneo Pharmaceuticals.

Diversification Opportunities for Bank Central and Reneo Pharmaceuticals

-0.35

Correlation Coefficient

Bank Central  Reneo Pharmaceuticals

Very good diversification

The 3 months correlation between Bank and Reneo is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Bank Central Asia and Reneo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reneo Pharmaceuticals and Bank Central is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank Central Asia are associated (or correlated) with Reneo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reneo Pharmaceuticals has no effect on the direction of Bank Central i.e., Bank Central and Reneo Pharmaceuticals go up and down completely randomly.

Pair Corralation between Bank Central and Reneo Pharmaceuticals

Assuming the 90 days horizon Bank Central Asia is expected to under-perform the Reneo Pharmaceuticals. But the pink sheet apears to be less risky and, when comparing its historical volatility, Bank Central Asia is 1.65 times less risky than Reneo Pharmaceuticals. The pink sheet trades about -0.16 of its potential returns per unit of risk. The Reneo Pharmaceuticals is currently generating about 0.53 of returns per unit of risk over similar time horizon. If you would invest  1,620  in Reneo Pharmaceuticals on September 26, 2024 and sell it today you would earn a total of  200.00  from holding Reneo Pharmaceuticals or generate 12.35% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	12.7%
Values	Daily Returns

Bank Central Asia  vs.  Reneo Pharmaceuticals

Bank Central Asia

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Bank Central Asia has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Reneo Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Excellent

Over the last 90 days Reneo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very unsteady technical indicators, Reneo Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Bank Central and Reneo Pharmaceuticals

The main advantage of trading using opposite Bank Central and Reneo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank Central position performs unexpectedly, Reneo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reneo Pharmaceuticals will offset losses from the drop in Reneo Pharmaceuticals' long position.

The idea behind Bank Central Asia and Reneo Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.